- By insider

CEO of Guardant Health Inc (GH) Helmy Eltoukhy sold 131,340 shares of GH on 05/01/2019 at an average price of $65.32 a share. The total sale was $8.6 million.

Guardant Health Inc has a market cap of $5.77 billion; its shares were traded at around $66.33 with and P/S ratio of 76.22.

• Warning! GuruFocus has detected 1 Warning Sign with GH. Click here to check it out.

• GH 15-Year Financial Data

• The intrinsic value of GH

• Peter Lynch Chart of GH

CEO Recent Trades:

• CEO Helmy Eltoukhy sold 131,340 shares of GH stock on 05/01/2019 at the average price of $65.32. The price of the stock has increased by 1.55% since.

• CEO Helmy Eltoukhy sold 90,000 shares of GH stock on 04/22/2019 at the average price of $65.28. The price of the stock has increased by 1.61% since.

Directors and Officers Recent Trades:

• Director Ian T Clark sold 538 shares of GH stock on 04/25/2019 at the average price of $65.11. The price of the stock has increased by 1.87% since.

• Chairman, President and COO Amirali Talasaz sold 117,540 shares of GH stock on 04/24/2019 at the average price of $66.69. The price of the stock has decreased by 0.54% since.

• Chairman, President and COO Amirali Talasaz sold 232,460 shares of GH stock on 04/22/2019 at the average price of $65.6. The price of the stock has increased by 1.11% since.

• Chief Legal Officer Michael J Wiley sold 90,000 shares of GH stock on 04/18/2019 at the average price of $69.79. The price of the stock has decreased by 4.96% since.

• Chief Medical Officer Richard B. Lanman sold 136,244 shares of GH stock on 04/17/2019 at the average price of $74.43. The price of the stock has decreased by 10.88% since.

For the complete insider trading history of GH, click here

.This article first appeared on GuruFocus.

• Warning! GuruFocus has detected 1 Warning Sign with GH. Click here to check it out.

• GH 15-Year Financial Data

• The intrinsic value of GH

• Peter Lynch Chart of GH